14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.11 $8.20 Thursday, 2nd May 2024 GLUE stock ended at $5.60. This is 5.72% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.84% from a day low at $5.35 to a day high of $5.93.
90 days $4.19 $8.84
52 weeks $2.44 $8.84

Historical Monte Rosa Therapeutics, Inc. prices

Date Open High Low Close Volume
Nov 01, 2023 $3.38 $3.63 $3.19 $3.42 390 992
Oct 31, 2023 $3.08 $3.46 $3.08 $3.40 184 941
Oct 30, 2023 $2.78 $3.24 $2.77 $3.10 284 072
Oct 27, 2023 $2.47 $2.84 $2.44 $2.78 376 150
Oct 26, 2023 $2.50 $2.62 $2.45 $2.50 234 327
Oct 25, 2023 $2.57 $2.60 $2.44 $2.50 201 472
Oct 24, 2023 $2.73 $2.82 $2.55 $2.58 353 495
Oct 23, 2023 $2.75 $2.87 $2.61 $2.65 329 331
Oct 20, 2023 $3.13 $3.13 $2.71 $2.74 311 018
Oct 19, 2023 $3.36 $3.55 $2.90 $3.13 597 323
Oct 18, 2023 $3.99 $4.05 $3.40 $3.43 729 997
Oct 17, 2023 $5.24 $5.24 $3.89 $4.01 3 403 121
Oct 16, 2023 $4.89 $5.06 $4.80 $5.00 105 701
Oct 13, 2023 $4.80 $4.89 $4.61 $4.83 125 179
Oct 12, 2023 $4.86 $4.86 $4.62 $4.76 210 985
Oct 11, 2023 $4.75 $4.90 $4.75 $4.88 117 465
Oct 10, 2023 $4.55 $4.83 $4.55 $4.74 124 027
Oct 09, 2023 $5.05 $5.05 $4.56 $4.61 194 185
Oct 06, 2023 $4.54 $5.26 $4.41 $5.07 229 976
Oct 05, 2023 $4.19 $4.56 $4.19 $4.55 264 449
Oct 04, 2023 $4.43 $4.43 $4.16 $4.24 128 407
Oct 03, 2023 $4.42 $4.72 $4.38 $4.47 195 893
Oct 02, 2023 $4.76 $4.76 $4.31 $4.52 220 038
Sep 29, 2023 $4.77 $4.82 $4.48 $4.79 271 237
Sep 28, 2023 $5.58 $5.58 $4.73 $4.78 262 451
Click to get the best stock tips daily for free!

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, ... GLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT